Page last updated: 2024-11-02

piribedil and Age-Related Memory Disorders

piribedil has been researched along with Age-Related Memory Disorders in 3 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Research Excerpts

ExcerptRelevanceReference
" Pronoran (piribedil) was used for treatment of age-related memory impairment in dosage 50 mg per day during 30 and 90 days (2 groups of 15 patients)."2.71[Efficacy of pronoran in age-related memory impairment]. ( Avedisova, AS; Bochkarev, VK; Faĭzulloev, AZ, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hastak, SM1
Bochkarev, VK1
Faĭzulloev, AZ1
Avedisova, AS1
Marighetto, A1
Valerio, S1
Philippin, JN1
Bertaina-Anglade, V1
Drieu la Rochelle, C1
Jaffard, R1
Morain, P1

Trials

2 trials available for piribedil and Age-Related Memory Disorders

ArticleYear
Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting.
    Journal of the Indian Medical Association, 2003, Volume: 101, Issue:8

    Topics: Aged; Aged, 80 and over; Dopamine Agonists; Family Practice; Female; Humans; India; Male; Memory Dis

2003
[Efficacy of pronoran in age-related memory impairment].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2005, Volume: 105, Issue:2

    Topics: Age Factors; Analysis of Variance; Dopamine Agonists; Female; Humans; Male; Memory; Memory Disorders

2005

Other Studies

1 other study available for piribedil and Age-Related Memory Disorders

ArticleYear
Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents.
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:5

    Topics: Aging; Animals; Antiparkinson Agents; Bromocriptine; Discrimination Learning; Disease Models, Animal

2008